Induction of insulin secretion in engineered liver cells by nitric oxide
2007

Engineering Liver Cells to Produce Insulin

Sample size: 5 publication 10 minutes Evidence: moderate

Author Information

Author(s): Muniappan Latha, Özcan Sabire

Primary Institution: University of Kentucky

Hypothesis

Can liver cells be engineered to produce and secrete insulin in response to nitric oxide?

Conclusion

Liver cells can be engineered to produce insulin and insulin secretion can be induced by treatment with L-arginine via the production of nitric oxide.

Supporting Evidence

  • Engineered liver cells can produce and secrete insulin when treated with L-arginine.
  • L-arginine increases insulin secretion up to three-fold via the nitric oxide pathway.
  • Insulin secretion was measured using an insulin ELISA kit.

Takeaway

Scientists can make liver cells act like insulin-producing cells, and they found that a substance called L-arginine can help these cells release insulin.

Methodology

Liver cells were engineered using adenoviral gene transfer to express human insulin and beta-cell specific transcription factors, and insulin secretion was measured after treatment with L-arginine.

Limitations

Insulin secretion from engineered cells was not very responsive to changes in glucose levels.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1472-6793-7-11

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication